Answers About Diagnosis and Treatment

No. Tumor type, stage, molecular features, previous treatments, and the patient general condition all influence treatment planning.

A second opinion can be helpful after a new diagnosis, before a major treatment decision, when treatment changes are being considered, or when NGS results are complex.

NGS is a genomic analysis that looks for molecular changes in a tumor and may help identify targeted therapies, immunotherapy options, or clinical trials.

No. The decision depends on tumor type, biomarkers such as PD-L1 or MSI/MMR, previous treatments, and medical risks.

An initial document review and second opinion can often be performed remotely, although some decisions may require an in-person examination.